Distinct pattern of striatal dopaminergic depletion in patients with parkin mutation
Objective: As a pilot study, this study was aimed to perform the detailed analysis of the striatal DAT density in patients with early-onset Parkinson's disease…SPECT imaging of striatal DAT availability in Parkinson’s: changes over time and relevance to dyskinesias
Objective: This study was designed to explore in Parkinson’s disease (PD) the role of dopamine transporter (DAT)-specific single photon emission computed tomography (SPECT) imaging as a…Utility of DaTscan Imaging in Differentiating Drug Induced Parkinsonism from IPD and Other Forms of Parkinsonism
Objective: To determine clinical correlates which differentiate drug induced Parkinsonism (DIP) from IPD and other forms of Parkinsonism using DaT-SPECT imaging. Background: DaT-SPECT imaging is…The brain plasticity for controlling reach-to-grasp functions of Parkinson’s disease
Objective: To investigate the brain plasticity for controlling the dominant and non-dominant hand muscles and reach-to-grasp (RTG) functions in Parkinson’s disease (PD). Background: Previous studies…Assessing Nigral Functional Connectivity in Parkinson’s Disease with Resting State Functional MRI
Objective: To evaluate functional connectivity of SN with basal ganglia and motor cortex in Parkinson’s disease (PD) using resting state functional MRI (RS fMRI). Background:…Globus Pallidus and Pedunculopontine Nucleus Oscillations during Executed and Imagined Gait in Patient with Parkinson’s Disease and Freezing of Gait Symptoms.
Objective: To explore neurophysiological markers of intentional executed and imagined movement in both Globus Pallidus Internus (Gpi) and Pedunculopontine Nucleus (PPN) in patients with Parkinson’s…Spanish Primary Familial Brain Calcification caused by SLC20A2 mutation
Objective: To describe clinical and radiological features of a Spanish family with Primary Familial Brain Calcification (PFBC) and genetic results of the index case. Background:…The SYNAPSES study (StudY to observe SafiNAmide in clinical Practice during the firSt post-commErcialization phaSe): methodology and results from the European feasibility survey
Objective: Here we present the design of a Drug Utilization Study of safinamide in the first post-commercialization phase and report results of the study feasibility…Serum cholesterol levels over time and risk of Parkinson’s disease
Objective: To evaluate the association of serum cholesterol levels over time with the risk of Parkinson's disease (PD); among statin-free individuals. Background: High levels of…Investigation of Non-Motor Symptoms Impacting Care Dependency in Individuals with Parkinson’s Disease
Objective: To examine what extent non-motor symptoms of Parkinson’s disease (PD) predict care dependence in individuals with PD. Background: The main aim of medical management…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.